Urinary System Adenocarcinoma — Trials

Urinary System Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,629 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 378
Recruiting: 195
Ph III recruiting: 14
Growth YoY: +1.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (279)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06428708	[18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma	unknown	Early Phase 1	30	Western UniversityOTHER	1	Jun 25, 2024	clinicaltrials
NCT05638256	68Ga-labeled NY104 PET Imaging in Patients	unknown	Early Phase 1	10	Affiliated Hospital of Jiangnan UniversityOTHER	1	Dec 6, 2022	clinicaltrials